1.02
price down icon9.73%   -0.11
after-market Dopo l'orario di chiusura: 1.02
loading
Precedente Chiudi:
$1.13
Aprire:
$1.12
Volume 24 ore:
1.30M
Relative Volume:
2.10
Capitalizzazione di mercato:
$15.38M
Reddito:
-
Utile/perdita netta:
$-11.90M
Rapporto P/E:
-0.00495
EPS:
-206.0125
Flusso di cassa netto:
$-12.75M
1 W Prestazione:
+2.00%
1M Prestazione:
-2.86%
6M Prestazione:
-25.00%
1 anno Prestazione:
+470.79%
Intervallo 1D:
Value
$0.9774
$1.13
Intervallo di 1 settimana:
Value
$0.945
$1.14
Portata 52W:
Value
$0.1131
$3.95

Allarity Therapeutics Inc Stock (ALLR) Company Profile

Name
Nome
Allarity Therapeutics Inc
Name
Telefono
401-426-4664
Name
Indirizzo
24 SCHOOL ST., 2ND FLOOR, BOSTON
Name
Dipendente
7
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
ALLR's Discussions on Twitter

Confronta ALLR con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ALLR
Allarity Therapeutics Inc
1.02 15.00M 0 -11.90M -12.75M -206.01
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Allarity Therapeutics Inc Borsa (ALLR) Ultime notizie

pulisher
Jul 24, 2025

Allarity Therapeutics Inc. Stock Analysis and ForecastFree Stock Market Query - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

What drives Allarity Therapeutics Inc. stock priceTremendous financial leverage - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

Is Allarity Therapeutics Inc. a good long term investmentMassive stock growth - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

How Allarity Therapeutics Inc. stock performs during market volatilityFree Stock Trading Community - Newser

Jul 22, 2025
pulisher
Jul 20, 2025

What analysts say about Allarity Therapeutics Inc. stockTremendous return rates - Autocar Professional

Jul 20, 2025
pulisher
Jul 18, 2025

Will Allarity Therapeutics Inc. stock benefit from interest rate changesFree Stock Investment Growth Plan - beatles.ru

Jul 18, 2025
pulisher
Jul 18, 2025

Does Allarity Therapeutics Inc. stock pay reliable dividendsRisk Adjusted Stock Signals - Newser

Jul 18, 2025
pulisher
Jul 16, 2025

Allarity Therapeutics Secures New EU Commercial Agreement - TipRanks

Jul 16, 2025
pulisher
Jul 16, 2025

Why Allarity Therapeutics Inc. stock attracts strong analyst attentionTop Rated Trade Entries - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Allarity Therapeutics Inc. stock price move sharplyReal Time Stock Signal - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Allarity Therapeutics Announces New Licensing and - GlobeNewswire

Jul 15, 2025
pulisher
Jul 15, 2025

Allarity Therapeutics Signs New Precision Oncology Licensing Deal for Breast Cancer | ALLR Stock News - Stock Titan

Jul 15, 2025
pulisher
Jul 13, 2025

Allarity Therapeutics appoints Jeff Ervin as CFO - MSN

Jul 13, 2025
pulisher
Jul 08, 2025

Jeffrey S. Ervin Appointed as Allarity’s New CFO - The Globe and Mail

Jul 08, 2025
pulisher
Jul 07, 2025

Allarity Therapeutics appoints Jeff Ervin as new CFO By Investing.com - Investing.com Nigeria

Jul 07, 2025
pulisher
Jul 07, 2025

Allarity Therapeutics, Inc. Announces Chief Financial Officer Changes - MarketScreener

Jul 07, 2025
pulisher
Jul 07, 2025

Allarity Therapeutics appoints Jeffrey S. Ervin as part-time chief financial officer - Investing.com Nigeria

Jul 07, 2025
pulisher
Jul 07, 2025

Allarity Therapeutics appoints Jeff Ervin as new CFO - Investing.com

Jul 07, 2025
pulisher
Jul 07, 2025

Allarity Therapeutics Appoints Jeff Ervin To Succeed Alexander Epshinsky As CFO - Nasdaq

Jul 07, 2025
pulisher
Jul 07, 2025

Allarity Therapeutics Appoints Jeff Ervin as New Chief Financial Officer - Nasdaq

Jul 07, 2025
pulisher
Jul 07, 2025

Allarity Therapeutics Announces Appointment of Jeff Ervin as Chief Financial Officer - GlobeNewswire

Jul 07, 2025
pulisher
Jul 07, 2025

Former NYSE Executive Takes CFO Role at Cancer Drug Developer Allarity Therapeutics - Stock Titan

Jul 07, 2025
pulisher
Jul 02, 2025

Allarity Therapeutics Secures Australian Patent for DRP® Platform - The Globe and Mail

Jul 02, 2025
pulisher
Jun 30, 2025

Allarity Therapeutics Advances Phase 2 Stenoparib Trial - TipRanks

Jun 30, 2025
pulisher
Jun 30, 2025

Allarity Therapeutics receives patent acceptance in Australia for cancer diagnostic - Investing.com

Jun 30, 2025
pulisher
Jun 30, 2025

Allarity Therapeutics Receives Australian Patent Acceptance Notice for Stenoparib DRP® Companion Diagnostic - The Manila Times

Jun 30, 2025
pulisher
Jun 27, 2025

Allarity Therapeutics Doses Second Patient in Phase 2 Ovarian Cancer Trial - MarketScreener

Jun 27, 2025
pulisher
Jun 17, 2025

Allarity Therapeutics Holds Annual Stockholders Meeting - TipRanks

Jun 17, 2025
pulisher
Jun 13, 2025

Allarity Therapeutics Stock Nears Yearly Low: A Trader’s High-Risk Analysis - thekhabrilal

Jun 13, 2025
pulisher
Jun 12, 2025

Allarity Therapeutics, Inc Announces Changes to Board of Directors - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

Allarity Therapeutics appoints pharma veteran Høiland to board - Investing.com India

Jun 12, 2025

Allarity Therapeutics Inc Azioni (ALLR) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):